Detection of Mycoplasma from nongonococcal urethritis patients and analysis of drug resistance
Long Huang
Abstract
Long Huang
Abstract
Objective To understand the status and drug resistance of Mycoplasma and provide basis for clinical medication. Methods 1 481 specimens from patients with nongonococcal urethritis(NGU) were cultured, meanwhile drug sensitivity test was conducted. Results Among the 683 samples, the positive rate of Ureaplasma urealyticum(Uu) and Mh infection were 43.69%(647/1 481) and 12.90%(191/ 1 481) repectively. Uu was sensitive to josamycin(89.48%) and minocycline (85.94%). Mh was sensitive to minocycline (78.01%) Mycoplasma infection in urogenital tract. Conclusion Minocycline is the first choice for treatment of Uu infection, and Minocycline or Doxycycline are the first choice for treatment of Mh infection.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To understand the status and drug resistance of Mycoplasma and provide basis for clinical medication. Methods 1 481 specimens from patients with nongonococcal urethritis(NGU) were cultured, meanwhile drug sensitivity test was conducted. Results Among the 683 samples, the positive rate of Ureaplasma urealyticum(Uu) and Mh infection were 43.69%(647/1 481) and 12.90%(191/ 1 481) repectively. Uu was sensitive to josamycin(89.48%) and minocycline (85.94%). Mh was sensitive to minocycline (78.01%) Mycoplasma infection in urogenital tract. Conclusion Minocycline is the first choice for treatment of Uu infection, and Minocycline or Doxycycline are the first choice for treatment of Mh infection.
Key concepts: Minocycline, Urethritis, Josamycin, Ureaplasma urealyticum, Doxycycline, Mycoplasma, Medicine, Genitourinary system